share_log

南京证券股份有限公司关于江苏诺泰澳赛诺生物制药股份有限公司新增2024年度日常关联交易预计事项的核查意见

Nanjing Securities Co., Ltd.'s verification opinion on the expected daily related party transactions of Jiangsu Novartis Ausino Bio-pharmaceutical Co., Ltd. in 2024.

Sensex a share ·  Jun 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more